Frequency of Prescription Claims for Drugs that May Interact with Janus Kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US

Introduction This study describes the frequency of prescription claims for drugs that may interact with Janus kinase (JAK) inhibitors among adult patients with rheumatoid arthritis (RA) in a large US claims database. Methods This observational, retrospective, cross-sectional study of the IBM ® Marke...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Rheumatology and Therapy 2021-03, Vol.8 (1), p.599-607
Hauptverfasser:	Walton, Alison, Paik, Jim, Quebe, Amanda, Kannowski, Carol L., Choong, Casey, Anderson, Seth, Owensby, Justin K.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse and side effects Brief Report Drug therapy Drugs Family Medicine General Practice Internal Medicine Medicine Medicine & Public Health Orthopedics Prescribing Quality of Life Research Rheumatoid arthritis Rheumatology Statistics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!